Cancer Genomics and Epigenetics

Welcome to "Cancer Genomics and Epigenetics," a distinguished and avant-garde journal dedicated to the forefront of cancer research. Here, we explore the intricate and nuanced interplay between genetics, epigenetic mechanisms, and cancer's multifaceted nature. This journal emerges as a beacon of enlightenment in the oncology community, offering groundbreaking insights and advancing the dialogue in cancer research, detection, and prevention.

Access policy: Open access
Review policy: Double-blind peer review
Frequency: Publish continuously

More info

Submit Paper

Join Our Esteemed Editorial Board!

We are excited to announce that Cancer Genomics and Epigenetics is now welcoming applications for new Editorial Board Members. This is a unique opportunity for experienced scholars and professionals to contribute to the advancement of research and be part of an international academic community.

Who We Are Looking For:

  • Experts with a strong publication record in Cancer Genomics and Epigenetics.
  • Researchers passionate about ensuring high-quality, peer-reviewed content.
  • Professionals with experience in journal editing, peer-reviewing, or academic publishing.

Responsibilities:

  • Review and provide feedback on submitted manuscripts.
  • Assist in shaping the journal’s editorial policies and scope.
  • Support special issue planning and new initiatives.

Benefits of Joining:

  • Collaborate with a network of renowned scholars.
  • Enhance your academic profile and visibility.
  • Gain recognition for your contributions in editorial work.

How to Apply:

To express your interest, please email the following documents to [email protected] by 31, October 2024.

  • Updated CV
  • Brief cover letter (explaining your expertise and motivation)
  • List of publications or areas of interest

We look forward to welcoming you to the Cancer Genomics and Epigenetics team and working together to advance knowledge in the field!

For any inquiries, feel free to contact us at [email protected]